(Updated - July 27, 2018 6:48 AM EDT)

Merck (NYSE: MRK) reported Q2 EPS of $1.06, $0.03 better than the analyst estimate of $1.03. Revenue for the quarter came in at $10.5 billion versus the consensus estimate of $10.29 billion.

GUIDANCE:

Merck sees FY2018 EPS of $4.22-$4.30. Merck narrowed its full-year 2018 revenue range to be between $42.0 billion and $42.8 billion vs $42.07 consensus.

For earnings history and earnings-related data on Merck (MRK) click here.